23andMe’s latest round of funding might signal a comeback

23andMe wants to expand its reach — and possibly its consumer health product line. The personal genomics company announced today that it had raised $115 million in venture capital financing. Part of that money will help the company expand its operations abroad, according to a press release. But Bloomberg reports that the money will also be used to accelerate work on a « revamped product with health analysis, » which 23andMe hopes to launch by the end of this year.

Continue reading…

Source: 23andMe's latest round of funding might signal a comeback

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *